World J Mens Health.  2021 Apr;39(2):233-290. 10.5534/wjmh.200196.

Utility of Antioxidants in the Treatment of Male Infertility: Clinical Guidelines Based on a Systematic Review and Analysis of Evidence

Affiliations
  • 1American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • 2School of Natural Medicine, Faculty of Community and Health Sciences, University of the Western Cape, Bellville, South Africa.
  • 3Department of Urology, Hamad Medical Corporation, Doha, Qatar.
  • 4Department of Urology, Weill Cornell Medicine - Qatar, Doha, Qatar.
  • 5Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • 6Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa.
  • 7Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA.
  • 8Department of Urology, Cleveland Clinic, Cleveland, OH, USA.
  • 9Department of Urology, Loma Linda University, Loma Linda, CA, USA.
  • 10Department of Surgery, Union Hospital, Hong Kong.
  • 11S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong.
  • 12Andrology Department, Cairo University, Giza, Egypt.
  • 13Department of Anatomy & Unit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
  • 14QOPNA & LAQV, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
  • 15Centro Androgen, La Coruña, Spain and Harvard Medical School, Boston, MA, USA.
  • 16Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India.

Abstract

It is widely accepted that oxidative stress plays an important role in the pathophysiology of male infertility and that antioxidants could have a significant role in the treatment of male infertility. The main objectives of this study are: 1) to systematically review the current evidence for the utility of antioxidants in the treatment of male infertility; and 2) propose evidence-based clinical guidelines for the use of antioxidants in the treatment of male infertility. A systematic review of the available clinical evidence was performed, with articles published on Scopus being manually screened. Data extracted included the type of antioxidant used, the clinical conditions under investigation, the evaluation of semen parameters and reproductive outcomes. The adherence to the Cambridge Quality Checklist, Cochrane Risk of Bias for randomized controlled trials (RCTs), CONSORT guidelines and JADAD score were analyzed for each included study. Further, we provided a Strength Weakness Opportunity Threat (SWOT) analysis to analyze the current and future value of antioxidants in male infertility. Of the 1,978 articles identified, 97 articles were included in the study. Of these, 52 (53.6%) were uncontrolled (open label), 12 (12.4%) unblinded RCTs, and 33 (34.0%) blinded RCTs, whereas 44 (45.4%) articles tested individual antioxidants, 31 (32.0%) a combination of several products in variable dosages, and 22 (22.6%) registered antioxidant products. Based on the published evidence, we 1) critically examined the necessity of additional double-blind, randomized, placebo-controlled trials, and 2) proposed updated evidence-based clinical guidelines for antioxidant therapy in male infertility. The current systematic review on antioxidants and male infertility clearly shows that antioxidant supplementation improves semen parameters. In addition, it provides the indications for antioxidant treatment in specific clinical conditions, including varicocele, unexplained and idiopathic male infertility, as well as in cases of altered semen quality.

Keyword

Antioxidants; Oxidative stress; Practice guideline; Semen analysis; Sperm maturation
Full Text Links
  • WJMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr